Cargando…
Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
BACKGROUND: Parkinson’s disease (PD) is a progressive neurodegenerative disease with characteristic pathological abnormalities, including the loss of dopaminergic (DA) neurons, a dopamine-depleted striatum, and microglial activation. Lipid accumulation exhibits a close relationship with these pathol...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895836/ https://www.ncbi.nlm.nih.gov/pubmed/36742201 http://dx.doi.org/10.3389/fnagi.2022.1077738 |
_version_ | 1784881930938875904 |
---|---|
author | Qiu, Jiewen Peng, Guoyou Tang, Yuting Li, Shiyin Liu, Zengfu Zheng, Jiayun Wang, Yunxin Liu, Hanqun Wei, Lijian Su, Yilin Lin, Yuwan Dai, Wei Zhang, Zhiling Chen, Xiang Ding, Liuyan Guo, Wenyuan Zhu, Xiaoqin Xu, Pingyi Mo, Mingshu |
author_facet | Qiu, Jiewen Peng, Guoyou Tang, Yuting Li, Shiyin Liu, Zengfu Zheng, Jiayun Wang, Yunxin Liu, Hanqun Wei, Lijian Su, Yilin Lin, Yuwan Dai, Wei Zhang, Zhiling Chen, Xiang Ding, Liuyan Guo, Wenyuan Zhu, Xiaoqin Xu, Pingyi Mo, Mingshu |
author_sort | Qiu, Jiewen |
collection | PubMed |
description | BACKGROUND: Parkinson’s disease (PD) is a progressive neurodegenerative disease with characteristic pathological abnormalities, including the loss of dopaminergic (DA) neurons, a dopamine-depleted striatum, and microglial activation. Lipid accumulation exhibits a close relationship with these pathologies in PD. METHODS: Here, 6-hydroxydopamine (6-OHDA) was used to construct a rat model of PD, and the lipid profile in cerebrospinal fluid (CSF) obtained from model rats was analyzed using lipidomic approaches. RESULTS: Establishment of this PD model was confirmed by apomorphine-induced rotation behaviors, loss of DA neurons, depletion of dopamine in the striatum, and microglial activation after 6-OHDA-induced lesion generation. Unsupervised and supervised methods were employed for lipid analysis. A total of 172 lipid species were identified in CSF and subsequently classified into 18 lipid families. Lipid families, including eicosanoids, triglyceride (TG), cholesterol ester (CE), and free fatty acid (FFA), and 11 lipid species exhibited significantly altered profiles 2 weeks after 6-OHDA administration, and significant changes in eicosanoids, TG, CE, CAR, and three lipid species were noted 5 weeks after 6-OHDA administration. During the period of 6-OHDA-induced lesion formation, the lipid families and species showed concentration fluctuations related to the recovery of behavior and nigrostriatal abnormalities. Correlation analysis showed that the levels of eicosanoids, CE, TG families, and TG (16:0_20:0_18:1) exhibited positive relationships with apomorphine-induced rotation behaviors and negative relationships with tyrosine hydroxylase (TH) expression in the midbrain. CONCLUSION: These results revealed that non-progressive nigrostriatal degeneration induced by 6-OHDA promotes the expression of an impairment-related lipidomic signature in CSF, and the level of eicosanoids, CE, TG families, and TG (16:0_20:0_18:1) in CSF may reveal pathological changes in the midbrain after 6-OHDA insult. |
format | Online Article Text |
id | pubmed-9895836 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98958362023-02-04 Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease Qiu, Jiewen Peng, Guoyou Tang, Yuting Li, Shiyin Liu, Zengfu Zheng, Jiayun Wang, Yunxin Liu, Hanqun Wei, Lijian Su, Yilin Lin, Yuwan Dai, Wei Zhang, Zhiling Chen, Xiang Ding, Liuyan Guo, Wenyuan Zhu, Xiaoqin Xu, Pingyi Mo, Mingshu Front Aging Neurosci Neuroscience BACKGROUND: Parkinson’s disease (PD) is a progressive neurodegenerative disease with characteristic pathological abnormalities, including the loss of dopaminergic (DA) neurons, a dopamine-depleted striatum, and microglial activation. Lipid accumulation exhibits a close relationship with these pathologies in PD. METHODS: Here, 6-hydroxydopamine (6-OHDA) was used to construct a rat model of PD, and the lipid profile in cerebrospinal fluid (CSF) obtained from model rats was analyzed using lipidomic approaches. RESULTS: Establishment of this PD model was confirmed by apomorphine-induced rotation behaviors, loss of DA neurons, depletion of dopamine in the striatum, and microglial activation after 6-OHDA-induced lesion generation. Unsupervised and supervised methods were employed for lipid analysis. A total of 172 lipid species were identified in CSF and subsequently classified into 18 lipid families. Lipid families, including eicosanoids, triglyceride (TG), cholesterol ester (CE), and free fatty acid (FFA), and 11 lipid species exhibited significantly altered profiles 2 weeks after 6-OHDA administration, and significant changes in eicosanoids, TG, CE, CAR, and three lipid species were noted 5 weeks after 6-OHDA administration. During the period of 6-OHDA-induced lesion formation, the lipid families and species showed concentration fluctuations related to the recovery of behavior and nigrostriatal abnormalities. Correlation analysis showed that the levels of eicosanoids, CE, TG families, and TG (16:0_20:0_18:1) exhibited positive relationships with apomorphine-induced rotation behaviors and negative relationships with tyrosine hydroxylase (TH) expression in the midbrain. CONCLUSION: These results revealed that non-progressive nigrostriatal degeneration induced by 6-OHDA promotes the expression of an impairment-related lipidomic signature in CSF, and the level of eicosanoids, CE, TG families, and TG (16:0_20:0_18:1) in CSF may reveal pathological changes in the midbrain after 6-OHDA insult. Frontiers Media S.A. 2023-01-20 /pmc/articles/PMC9895836/ /pubmed/36742201 http://dx.doi.org/10.3389/fnagi.2022.1077738 Text en Copyright © 2023 Qiu, Peng, Tang, Li, Liu, Zheng, Wang, Liu, Wei, Su, Lin, Dai, Zhang, Chen, Ding, Guo, Zhu, Xu and Mo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Qiu, Jiewen Peng, Guoyou Tang, Yuting Li, Shiyin Liu, Zengfu Zheng, Jiayun Wang, Yunxin Liu, Hanqun Wei, Lijian Su, Yilin Lin, Yuwan Dai, Wei Zhang, Zhiling Chen, Xiang Ding, Liuyan Guo, Wenyuan Zhu, Xiaoqin Xu, Pingyi Mo, Mingshu Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease |
title | Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease |
title_full | Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease |
title_fullStr | Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease |
title_full_unstemmed | Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease |
title_short | Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease |
title_sort | lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of parkinson’s disease |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895836/ https://www.ncbi.nlm.nih.gov/pubmed/36742201 http://dx.doi.org/10.3389/fnagi.2022.1077738 |
work_keys_str_mv | AT qiujiewen lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT pengguoyou lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT tangyuting lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT lishiyin lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT liuzengfu lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT zhengjiayun lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT wangyunxin lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT liuhanqun lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT weilijian lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT suyilin lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT linyuwan lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT daiwei lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT zhangzhiling lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT chenxiang lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT dingliuyan lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT guowenyuan lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT zhuxiaoqin lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT xupingyi lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease AT momingshu lipidprofilesinthecerebrospinalfluidofratswith6hydroxydopamineinducedlesionsasamodelofparkinsonsdisease |